Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...

At the risk of sounding like investing guru Cathie Wood, Tesla (NASDAQ:TSLA) has a clear path to be a $20 trillion stock. The pioneer in electric vehicles (EVs) and sustainable energy has transformed ...

Tesla’s bold promises of self-driving cars and robotaxis are colliding with disappointing sales, regulatory roadblocks, and growing investor doubt, as the company’s latest earnings report shows ...

Neuralink, Elon Musk’s brain chip company, has partnered with researchers in Spain and California on a new clinical trial for what’s being called a “Smart Bionic Eye.” The trial quietly appeared on ...

Tesla shares plummeted as CEO Elon Musk’s promises for robotaxis failed to excite investors following another disappointing ...

No slides was our first rule,” McNeil told the audience earlier this month at TC All Stage in Boston. “You have to be ...